Nano X Imaging Ltd

Nano X Imaging Ltd

NNOX · NASDAQ · Healthcare / Medical Devices

0.3221USD+0.00 (+1.16%)

Price History

Full chart

Market Stats

Previous Close0.3184
Open0.37
Day Range0.31 – 0.3792
52-Week Range0.63 – 4.71
Volume2.74M
Market Cap50.31M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.72
Dividend Yield0.00%
Beta1.25
50-Day Avg0.8907
200-Day Avg1.93

About

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Elli Yuz
  • Employees197
  • Headquarters94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602, USA
  • Websitehttps://www.nanox.vision

Leadership

  • Ms. Tamar Aharon CohenExecutive VP & Chief Marketing Officer · b. 1977
  • Mr. James M. DaraGM of Source & Services Division and Head of Nanox USA · b. 1970
  • Mr. Guy NathanzonChief Financial Officer · b. 1972
  • Ms. Marina Gofman FelerChief Legal Officer · b. 1989
  • Dr. Ilung Kim Ph.D.Head of Nanox Korea · b. 1959
  • Ms. Gali Yahav AttiasChief of Corporate Resources · b. 1979
  • Dr. Michael Yuz M.D., MBAPresident & CMO, USARAD Holdings Inc.
  • Ms. Elli YuzCEO OF USARAD Holdings Inc.

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0001.30M8.58M9.90M11.28M13.02M
Growth (%)----+557.82%+15.47%+13.91%+15.40%
Cost of Revenue35.00K53.00K208.00K2.82M15.46M16.50M21.89M25.81M
Gross Profit-35.00K-53.00K-208.00K-1.51M-6.88M-6.59M-10.61M-12.79M
Gross Margin----115.95%-80.21%-66.55%-94.03%-98.21%
Operating Expense1.87M22.52M43.72M60.05M102.83M56.00M46.14M47.91M
Operating Income-1.90M-22.57M-43.92M-61.56M-109.71M-62.59M-56.75M-60.70M
Operating Margin----4720.71%-1278.97%-631.89%-502.93%-466.16%
EBITDA-1.87M-22.52M-43.72M-59.27M-75.70M-47.69M-45.01M-49.00M
EBITDA Margin----4544.94%-882.44%-481.50%-398.95%-376.33%
Net Income-1.91M-22.55M-43.50M-61.80M-105.24M-60.78M-53.52M-75.02M
Net Income Margin----4739.11%-1226.89%-613.59%-474.31%-576.13%
R&D672.00K2.72M9.21M17.12M26.51M26.05M20.18M19.24M
R&D as % of Total Revenue---1313.04%309.01%262.99%178.87%147.73%
Interest Expense5.00K8.00K108.00K2.00M60.22M---
Interest Expense % of Total Revenue---153.68%701.97%---

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.85M11.87M236.15M363.17M253.93M218.65M210.00M162.16M
Total Liabilities8.24M20.65M5.40M71.02M37.25M23.13M20.88M22.43M
Total Equity-6.38M-8.78M230.75M292.15M216.68M195.51M189.12M139.73M
Cash5.00K8.07M213.47M66.64M38.46M56.38M39.30M49.15M
Total Debt-526.00K1.44M5.77M4.62M8.40M7.45M7.85M
Net Debt-5.00K-7.55M-212.03M-60.87M-33.84M-47.98M-31.86M-41.30M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.67M-5.52M-21.49M-38.07M-43.38M-44.78M-36.60M-40.79M
Investing Cash Flow-73.00K-125.00K-13.94M-116.32M14.61M35.43M-20.05M29.37M
Financing Cash Flow3.68M13.86M240.99M7.38M804.00K27.25M39.50M21.37M
Capital Expenditure73.00K125.00K13.94M23.16M7.17M3.30M2.77M4.21M
Free Cash Flow-3.74M-5.65M-35.42M-61.23M-50.56M-48.08M-39.37M-45.00M
FCF to OCF101.99%102.26%164.86%160.83%116.53%107.38%107.56%110.31%

Earnings

Report DateJan 14, 2020Jul 31, 2020Nov 9, 2020Mar 2, 2021May 11, 2021Aug 10, 2021Nov 17, 2021Mar 31, 2022May 19, 2022Aug 16, 2022Nov 10, 2022Mar 9, 2023May 22, 2023Aug 17, 2023Nov 28, 2023Mar 7, 2024May 28, 2024Aug 20, 2024Nov 21, 2024Mar 31, 2025May 22, 2025Aug 12, 2025Nov 20, 2025Dec 31, 2025Jun 25, 2026Sep 9, 2026Nov 19, 2026
EPS Estimate0.00-0.23-0.27-0.20-0.27-0.20-0.28-0.33-0.22-0.25-0.42-0.43-0.34-0.26-0.30-0.30-0.26-0.15-0.15-0.15-0.15-0.15-0.17-0.15-0.14-0.12-0.14
EPS Actual-0.51-0.02-0.13-0.18-0.15-0.18-0.28-0.45-0.41-0.38-0.37-0.86-0.21-0.31-0.37-0.18-0.21-0.14-0.15-0.17-0.15-0.17-0.15-0.17-0.20-0.79-
Surprise-91.30%51.85%10.00%44.44%10.00%0.00%-36.36%-86.36%-52.00%11.90%-100.00%38.24%-19.23%-23.33%40.00%19.23%6.67%0.00%-13.33%0.00%-13.33%11.76%-13.33%-42.86%-558.33%-
TimingAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap50.31M
Enterprise Value31.54M
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.22
Price / Book0.76
EPS-1.72
Book Value1.82
Revenue (TTM)15.63M
Gross Profit (TTM)-12.07M
EBITDA-49.95M
Profit Margin0.00%
Operating Margin-355.34%
Return on Equity-98.98%
Return on Assets-27.86%
Shares Outstanding78.59M
Shares Float64.35M
Beta1.25
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 4.13
  • Strong Buy
    4

Ownership Breakdown

Institutions
13.25%
Insiders
7.18%
Retail / Other
79.57%

Top Institutional Holders

  • BlackRock Inc
    3.82M5.41%
  • Weiss Asset Management LP
    2.79M3.96%
  • UBS Group AG
    1.35M1.91%
  • State Street Corp
    1.22M1.73%
  • Geode Capital Management, LLC
    893.10K1.27%
  • ARK Investment Management LLC
    733.29K1.04%
  • Northern Trust Corp
    524.29K0.74%
  • AQR Capital Management LLC
    494.69K0.70%
  • Bank of America Corp
    484.33K0.69%
  • Morgan Stanley - Brokerage Accounts
    476.37K0.67%
  • Vanguard Portfolio Management, LLC
    404.76K0.57%
  • Citigroup Inc
    404.59K0.57%
  • The Goldman Sachs Group Inc
    378.94K0.54%
  • Royal Bank of Canada
    194.17K0.28%
  • Bank of New York Mellon Corp
    168.72K0.24%
  • Charles Schwab Investment Management Inc
    153.49K0.22%
  • Nuveen, LLC
    152.05K0.22%
  • Schonfeld Strategic Advisors LLC
    139.00K0.20%

Top Fund Holders

  • iShares Micro-Cap ETF
    237.67K0.34%
  • State Street® SPDR® Ptf Dev Wld exUS ETF
    197.16K0.28%